Breakthrough drugs target kidney damage in diabetes

NCT ID NCT07271186

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing two experimental drugs, ALN-ANG3 and evinacumab, to see if they can help control diabetic kidney disease. The main goal is to see if the drugs safely reduce protein in the urine, a key sign of kidney damage. The trial will involve about 270 adults with type 2 diabetes and moderate to severe kidney problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AGA Clinical Trials
RECRUITING

Hialeah, Florida, 33012, United States
Amicis Research Center
RECRUITING

Northridge, California, 91325, United States
Amicis Research Center
RECRUITING

Santa Clarita, California, 91355, United States
Amicis Research Center
RECRUITING

Valencia, California, 91355, United States
Applied Research Center of Arkansas
RECRUITING

Little Rock, Arkansas, 72205, United States
Arlington Nephrology, PLLC.
RECRUITING

Arlington, Texas, 76015, United States
Bolanos Clinical Research
RECRUITING

Pembroke Pines, Florida, 33026, United States
Brookview Hills Research Associates, LLC
RECRUITING

Winston-Salem, North Carolina, 27103, United States
Central Coast Nephrology
RECRUITING

Salinas, California, 93901, United States
Clinical Research Consultants, LLC
RECRUITING

Kansas City, Missouri, 64111, United States
Clinical Trial Network, LLC
RECRUITING

Houston, Texas, 77074, United States
Convenient Medical Center
RECRUITING

Hialeah, Florida, 33013, United States
D&H Doral Research Center
RECRUITING

Doral, Florida, 33122, United States
D&H National Research Centers, Inc
RECRUITING

Miami, Florida, 33155, United States
D&H Pompano Research Center
RECRUITING

Margate, Florida, 33063, United States
D&H Tamarac Research Center
RECRUITING

Tamarac, Florida, 33321, United States
Elixia Hollywood
RECRUITING

Hollywood, Florida, 33024, United States
Elixia MNA
RECRUITING

City of Saint Peters, Missouri, 63376, United States
Elixia Michigan Kidney Consultants
RECRUITING

Pontiac, Michigan, 48341, United States
Innovia Research Center
RECRUITING

Miramar, Florida, 33027, United States
LCC Medical Research Institute
RECRUITING

Miami, Florida, 33126, United States
Metabolic Research Institute
RECRUITING

West Palm Beach, Florida, 33401, United States
North America Research Institute
RECRUITING

San Dimas, California, 91773, United States
Northeast Clinical Research Center
RECRUITING

Bethlehem, Pennsylvania, 18017, United States
Ocean Blue Medical Research Center - Internal Medicine
RECRUITING

Miami Springs, Florida, 33166, United States
Regenerate Primary Medical Research, LLC
RECRUITING

Miami, Florida, 33155, United States
Research by Design, LLC - Internal Medicine
RECRUITING

Chicago, Illinois, 60643, United States
Southeast Renal Research Institute
RECRUITING

Chattanooga, Tennessee, 37404, United States
Suburban Research Associates
RECRUITING

West Chester, Pennsylvania, 19380, United States

Conditions

Explore the condition pages connected to this study.

DIABETIC KIDNEY DISEASE (DKD)